CEP120

Across TCGA pan-cancer cohorts, CEP120 RNA differs between tumor and matched normal tissue in 14 of 18 cancer types tested, making tumor–normal expression one of CEP120’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where CEP120 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types CEP120 is over-expressed in tumor, although a few such as LUSC and THCA show the opposite, repressed pattern.

KIRC, LUSC, and THCA are the cancer types where CEP120 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in CEP120 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	Male	All	+0.521	<.001	9	view →
LUSC	Female	All	−0.710	<.001	8	view →
THCA	Female	All	−0.555	<.001	8	view →
UCEC	All	All	−1.245	<.001	6	view →
HNSC	All	All	+0.400	.001	6	view →
CHOL	All	All	+0.974	<.001	5	view →
LUAD	Female	II,III,IV	−0.564	.003	5	view →
BRCA	Female	All	−0.333	<.001	4	view →
KICH	Female	All	−1.186	.001	3	view →
STAD	All	II,III,IV	+0.589	.011	2	view →
ESCA	All	All	+0.471	.015	2	view →
PRAD	All	All	−0.363	<.001	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 12 strongest of 14 lineages.

CEP120–KIRC

Open the KIRC breakdown →